Extracorporeal circulation influence on plasma atrial natriuretic peptide concentration in cardiac surgery patients.

An attempt was made to clarify the change of plasma human atrial natriuretic peptide (hANP) concentration before, during, and after cardiac surgery in heart failure with extracorporeal circulation. Plasma hANP concentration did not significantly decrease during total aortic cross clamping (ACC) with complete clamping of the superior and inferior vena cavae. This finding may be explained by the suppression of endopeptidase activities and the response of hANP receptors due to the low body temperature. Plasma hANP concentration strongly increased from 56.6 +/- 8.4 to 208.9 +/- 40.7 pg/ml (n = 5) by the release of total ACC. This strong increase of hANP in the plasma may occur due to the rapid increase of atrial pressure from zero to 12.5 mm Hg caused by releasing the total ACC. The molecular form of plasma hANP obtained after the release of total ACC was alpha-hANP alone, which was estimated by gel permeation chromatography and reverse HPLC.

[1]  F. Marumo,et al.  The presence of atrial natriuretic peptide in canine cerebrospinal fluid and its possible origin in the brain. , 1988, The Journal of endocrinology.

[2]  H. Itoh,et al.  Atrial natriuretic polypeptide (ANP) in human ventricle. Increased gene expression of ANP in dilated cardiomyopathy. , 1987, Biochemical and biophysical research communications.

[3]  F. Marumo,et al.  Presence of the atrial natriuretic peptide in human cerebrospinal fluid. , 1987, Biochemical and biophysical research communications.

[4]  P. Erne,et al.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.

[5]  F. Marumo,et al.  A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. , 1986, Biochemical and biophysical research communications.

[6]  R. Cuneo,et al.  Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. , 1986, Life sciences.

[7]  A. Shore,et al.  ATRIAL NATRIURETIC PEPTIDE LEVELS IN TREATED CONGESTIVE HEART FAILURE , 1986, The Lancet.

[8]  C. Johnston,et al.  EFFECTS OF POSTURE ON CIRCULATING ATRIAL NATRIURETIC PEPTIDE , 1985, The Lancet.

[9]  K. Nakao,et al.  Atrial natriuretic polypeptide: Topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry , 1985, Neuroscience.

[10]  F. Takaku,et al.  Atrial natriuretic factor in human blood. , 1985, The Journal of clinical investigation.

[11]  K. Nakao,et al.  Occurrence of atrial natriuretic polypeptide in brain. , 1985, Biochemical and biophysical research communications.

[12]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[13]  Longmore Db.  ELECTRICAL STIMULATION OF THE BLADDER: A NEW PROSPECT AFTER SPINAL INJURY? , 1965 .

[14]  H. Itoh,et al.  The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects. , 1986, European journal of clinical pharmacology.

[15]  K. Kangawa,et al.  Structural identification of β- and γ-human atrial natriuretic polypeptides , 1985, Nature.

[16]  K. Kangawa,et al.  Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). , 1984, Biochemical and biophysical research communications.